D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+70,000→ 70,000 totalExercise: $4.45Exp: 2035-01-27→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]One-third of the total number of shares subject to the option shall vest on the 12 month anniversary of January 28, 2025, and one-thirty-sixth of the other two-thirds of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to continuous service to the Company on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.